EPISODE · Apr 24, 2023 · 25 MIN
Metastatic Melanoma: Incorporating Lymphocyte-Activation Gene 3 Inhibitors Into the Treatment Paradigm
from Keeping Current CME
Are you up to date on the use of lymphocyte-activation gene 3 (LAG3) inhibitors to treat patients with metastatic melanoma? Credit available for this activity expires: 04/21/24 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/990930?ecd=bdc_podcast_libsyn_mscpedu
Embed this episode
NOW PLAYING
Metastatic Melanoma: Incorporating Lymphocyte-Activation Gene 3 Inhibitors Into the Treatment Paradigm
0:00
25:40
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of Keeping Current CME?
This episode is 25 minutes long.
When was this Keeping Current CME episode published?
This episode was published on April 24, 2023.
Can I download this Keeping Current CME episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!